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The optimal treatment of multiple cutaneous and subcutaneous metastases of melanoma
still remains unresolved. There are many different possible treatment modalities. We pres-
ent a case of melanoma on the calf in which multiple cutaneous and subcutaneous metas-
tases were treated by electrochemotherapy with cisplatin. They completely responded for
eight years. After eight years two new metastatic nodules occurred and were treated by
electrochemotherapy with cisplatin and again complete response was achieved. The case
presents the advantages of electrochemotherapy of multiple cutaneous and subcutaneous
metastases of melanoma, its relative simplicity, its minimal side effects and the possibility
to treat recurrent disease as many times as needed, with long lasting complete responses.
 2006 Elsevier Ltd. All rights reserved.er Ltd. All
34.
a).1. Introduction
Themultiple cutaneous and subcutaneousmetastases of mel-
anoma are a condition which is difficult to treat with curative
intent. There are different modalities in use. When nodules
are conveniently located the surgical excision is performed.
Radiotherapy,1 isolated limb perfusions and infusions2 and la-
ser therapy could be employed when surgery is not feasible.
Another possible modality is electrochemotherapy.3–5
We present a case of a patient with multiple cutaneous
and subcutaneous metastases of the melanoma treated by
electrochemotherapy with cisplatin. With this treatment long
standing complete response was obtained.
2. Case report
Fifty-seven years old female patient was operated upon in
1992, with wide excision of a melanoma of Breslow thickness
1.3 mm on the anterior side of left ankle. No further treat-rights reservedment was given at that time. Patient fared well until January
1997 when multiple cutaneous and subcutaneous nodules
(16 nodules) were observed on right calf, verified by fine nee-
dle aspiration biopsy as metastases of melanoma (Fig. 1). The
size of the nodules ranged from 4 · 4 mm to 17 · 18 mm in
diameters. The US of the abdomen and chest X-rays did not
show any signs of metastases. From February to May 1997
the patient was treated by electrochemotherapy. Altogether
five sessions were performed. First three sessions were per-
formed with weekly intervals. The fourth session was per-
formed 2 weeks after the third one. The fifth one was
performed in May 1997 when new 16 · 16 mm metastasis on
the inner side of right thigh emerged. The treatment was per-
formed by intratumoural injection of cisplatin (cis-diammin-
edichloroplatinum II; Platinol, Bristol-Myers Squibb, Vienna,
Austria) in concentration of 1 mg/100 mm3 of tumour nodule.
The interval between cisplatin injection and the application
of electric pulses was 1–2 min. Square wave electric pulses
of 100 ls, 910 V amplitude (amplitude/electrode distance ratio.
Fig. 1 – Response of melanoma tumour nodules to single treatment by electrochemotherapy using cisplatin. Nodules were
treated with intratumoural injection of cisplatin and 1–2 min afterward exposed to electric pulses. Two months after
treatment crusts are visible on some of the treated nodules, which fell off. Good cosmetic effect without visible scaring 6 and
8 years after treatment without recurrences.
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stainless steel electrodes with inner distance between them
7 mm, using an electric pulse generator Jouan GHT 1287
(Jouan, St. Herblain, France). Nodules larger than 7 mm in
diameter were treated with several runs of electric pulses
administered in adjacent positions to assure adequate cover-
age of the whole tumour area. By August 1997 all metastases
were in complete response except the tumour on the ankle
which grew to 6 cm with superficial ulceration. This nodule
was then treated by excision and cryosurgery of the base.
Its histology revealed the metastasis of epiteloid melanoma
with infiltration of the resection surface. By November 1997
the wound was completely healed by secondary intention
and all nodules treated by electrochemotherapy were in com-
plete response. The treated nodules were at first erythema-
tous and slight oedema was observed, which remained for
two weeks. Thereafter a superficial crust was formed on the
treated nodules which fell off in approximately in 4–8 weeks
(Fig. 1). After the crust fell off, the skin in the treated areawas slightly depigmented with minimal retraction. However,
these changes in the skin disappeared with time as during
regular follow ups the primary position of the treated nodules
was difficult or impossible to locate (Fig. 1).
Patient was in complete response till August 2005, when
two subcutaneous metastases on right leg emerged, one
was located below the knee (7 · 7 mm) and the second above
it (13 · 11 mm). They were treated by electrochemotherapy
with cisplatin with the same drug dosage and electrical
parameters as in the first course of treatment using the elec-
tric pulse generator CLINIPORATORTM (IGEA srl. Carpi, Italy).
The same development of the treatment response was ob-
served and in November 2005 complete response was
observed.
3. Discussion
Case presented is showing that multiple cutaneous and sub-
cutaneous metastases of melanoma could be treated by
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plete response of eight years.
The multiple cutaneous and subcutaneous metastases of
melanoma are believed to be the result of intralymphatic
spread of tumour cells. Therefore the longstanding complete
remission is difficult to obtain and cures are very rare. The
treatment modality which is the most appropriate if nodules
are few and conveniently located is surgical excision. It is
obviously limited by the ability to obtain skin closure, which
is sometimes achievedwith skin grafting. When surgical exci-
sion is not feasible and tumours are located on the extremi-
ties, isolated limb infusion and perfusion could be the
option. The drawback of the procedure is its relative complex-
ity imposing that it could be performed in few cancer centers
with resources and competence. Although the isolated limb
perfusion might have high complete response rate as 90%,
remission rate is high as 50%, the corresponding median limb
disease free interval is of only short duration, 9.5 months.6
When it comes to recurrence after limb perfusion a second
limb perfusion might be done which is even more technically
demanding than the first one.7 In some centres laser evapora-
tion of melanoma nodules is performed which is resulting in
defects which are healed by secondary intention for quite
some time and are prone to infection.8
All these drawbacks of different modalities of treatment of
multiple cutaneous and subcutaneous metastases of mela-
noma might be overcome with electrochemotherapy taking
long lasting complete response as its definite advantage.
The electrochemotherapy is an easy, fast and effective proce-
dure which can be repeated as much as needed. Furthermore
thewounds are not healed by secondary intention as tumours
are diminishing in its size. All these advantages are presented
in our case.
Furthermore, this case clearly demonstrates that electr-
ochemotherapy can be repeated several times with equally
good antitumour effectiveness indicating that melanoma
cells in new emerging metastases did not have acquired resis-
tance to cisplatin.Acknowledgements
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